Literature DB >> 2873010

Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving.

C Harrison, Z Subhan, I Hindmarch.   

Abstract

A double-blind, randomized, cross-over study was carried out in 10 normal healthy volunteers to investigate the residual effects of 7.5 mg zopiclone, 1 mg lormetazepam, 0.25 mg triazolam, 1 mg flunitrazepam and placebo. Tests of psychomotor performance and analogues of car driving ability were administered the morning following night-time medication. Changes with respect to placebo in an information-processing task one hour after taking the medications confirmed the hypnotic efficacy of zopiclone, triazolam and flunitrazepam. Flunitrazepam also produced a significant depression of the Critical Flicker Fusion Threshold (CFF) and increased subjective ratings of sedation one hour after nocturnal dosing. Flunitrazepam impaired the reaction time on the information-processing test the morning following doses of 1 mg.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2873010

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  8 in total

1.  A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone.

Authors:  Arthur A Simen; Cynthia Gargano; Jang-Ho Cha; Melissa Drexel; An Bautmans; Ingeborg Heirman; Tine Laethem; Thomas Hochadel; Lien Gheyle; Kim Bleys; Chan Beals; Aubrey Stoch; Gary G Kay; Arie Struyk
Journal:  Ther Adv Drug Saf       Date:  2015-06

2.  Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests.

Authors:  T Kuitunen; M J Mattila; T Seppälä; K Aranko; M E Mattila
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

3.  Consensus on drug treatment, definition and diagnosis for insomnia.

Authors:  E Estivill; A Bové; D García-Borreguero; J Gibert; J Paniagua; G Pin; F J Puertas; R Cilveti
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

4.  The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers.

Authors:  D B Fairweather; J S Kerr; I Hindmarch
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.

Authors:  K L Goa; R C Heel
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

6.  Evaluation of the effect of pregabalin on simulated driving ability using a driving simulator in healthy male volunteers.

Authors:  Tomoaki Tujii; Win Thiri Kyaw; Hirotaka Iwaki; Noriko Nishikawa; Masahiro Nagai; Madoka Kubo; Masahiro Nomoto
Journal:  Int J Gen Med       Date:  2014-01-29

7.  Enhancing behavioral sleep care with digital technology: study protocol for a hybrid type 3 implementation-effectiveness randomized trial.

Authors:  Anne Germain; Rachel R Markwald; Erika King; Adam D Bramoweth; Megan Wolfson; Gilbert Seda; Tony Han; Erin Miggantz; Brian O'Reilly; Lars Hungerford; Traci Sitzer; Vincent Mysliwiec; Joseph J Hout; Meredith L Wallace
Journal:  Trials       Date:  2021-01-11       Impact factor: 2.279

8.  Eszopiclone: its use in the treatment of insomnia.

Authors:  Jaime M Monti; S R Pandi-Perumal
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.